Business process reporting using process mining, analytic workflows and process cubes: A case study in education

Business Process Intelligence (BPI) is an emerging topic that has gained popularity in the last decade. It is driven by the need for analysis techniques that allow businesses to understand and improve their processes. One of the most common applications of BPI is reporting, which consists on the structured generation of information (i.e., reports) from raw data. In this article, state-of-the-art process mining techniques are used to periodically produce automated reports that relate the actual performance of students of a Dutch University to their studying behavior. To avoid the tedious manual repetition of the same process mining procedure for each course, we have designed a workflow calling various process mining techniques using RapidProM. To ensure that the actual students’ behavior is related to their actual performance (i.e., grades for courses), our analytic workflows approach leverages on process cubes, which enable the dataset to be sliced and diced based on courses and grades. The article discusses how the approach has been operationalized and what is the structure and concrete results of the reports that have been automatically generated. Two evaluations were performed with lecturers using the real reports. During the second evaluation round, the reports were restructured based on the feedback from the first evaluation round. Also, we analyzed an example report to show the range of insights that they provide

A visual approach to spot statistically-significant differences in event logs based on process metrics

This paper addresses the problem of comparing different variants of the same process. We aim to detect relevant differences between processes based on what was recorded in event logs. We use transition systems to model behavior and to highlight differences. Transition systems are annotated with measurements, used to compare the behavior in the variants. The results are visualized as transitions systems, which are colored to pinpoint the significant differences. The approach has been implemented in ProM, and the implementation is publicly available. We validated our approach by performing experiments using real-life event data. The results show how our technique is able to detect relevant differences undetected by previous approaches while it avoids detecting insignificant differences

Who are my ancestors? : retrieving family relationships from historical texts

This paper presents an approach for automatically retrieving family relationships from a real-world collection of Dutch historical notary acts. We aim to retrieve relationships like husband - wife, parent - child, widow of, etc. Our approach includes person names extraction, reference disambiguation, candidate generation and family relationship prediction. Since we have a limited amount of training data, we evaluate different feature configurations based on the n-gram analysis. The best results were obtained by using a combination of bi-grams and trigrams of words together with the distance in words between two names. We evaluate our results for each type of the relationships in terms of precision, recall and f - score

Finding process variants in event logs (short paper)

The analysis of event data is particularly challenging when there is a lot of variability. Existing approaches can detect variants in very specific settings (e.g., changes of control-flow over time), or do not use statistical testing to decide whether a variant is relevant or not. In this paper, we introduce an unsupervised and generic technique to detect significant variants in event logs by applying existing, well-proven data mining techniques for recursive partitioning driven by conditional inference over event attributes. The approach has been fully implemented and is freely available as a ProM plugin. Finally, we validated our approach by applying it to a real-life event log obtained from a multinational Spanish telecommunications and broadband company, obtaining valuable insights directly from the event data

Global catastrophes in earth history: an interdiciplinary conference on impacts, volcanism, and mass mortality.

Topics addressed include Cretaceous-Tertiary mass extinctions; geological indicators for meteorite collisions; carbon dioxide catastrophes; volcanism; climatic changes; geochemistry; mineralogy; fossil records; biospheric traumas; stratigraphy; mathematical models; and ocean dynamics

Modern and ancient amalgamated sandy meander‐belt deposits: recognition and controls on development

Amalgamated sandy meander belts and their deposits are common in modern continental and marine‐connected basins yet comprise a minor constituent of the reported fluvial rock record. This suggests that either amalgamated meander‐belts are uncommon in the rock record or that the recognition criteria are lacking to identify sandy meandering river deposits. To address this apparent discrepancy, the authors document the range and occurrence of amalgamated sandy meander belts (ASMB) from modern basins and the stratigraphic record. ASMB are widely distributed throughout both present and rock record sedimentary basins occurring in foreland, extensional, cratonic, strike‐slip and passive margin basins. They occur in all climatic settings ranging from tundra to hot deserts. Three specific occurrences of ASMB are recognised in modern basins: in the proximal to medial parts of distributive fluvial systems (DFS), as laterally‐confined belts that mainly form axial fluvial systems; and as valley‐confined meander belts that may infill bedrock, alluvial or coastal plain valleys. From the limited amount of rock record examples of ASMB that are available, it is clear that they occur in similar settings to those observed in modern basins, the recognition of which provides a framework for the further prediction and identification of ASMB in the rock record. The lack of recognition of ASMB in the rock record is considered to be due to an absence of characteristics that allow clear distinction between sandy meandering and braided fluvial deposits. Characteristics considered common to both include: multi‐storey, laterally extensive (sheet‐like) amalgamated channel belts, dominance of downstream accreting bedforms, no fining upwards grain‐size profile and little or no fine‐grained sediment and/or soil preservation. In contrast, features considered characteristic of meandering rivers such as inclined heterolithic stratification, high palaeocurrent dispersion, single storey channels and fining upwards grain‐size profiles are absent. The authors suggest that no single criterion can be used to definitively identify sandy meander belt deposits in the rock record and that a combination of systematic variations in accretion direction, palaeocurrent dispersal patterns and recognition of storey scale accretion surfaces is necessary to identify clearly this fluvial style. The common occurrence and distribution of sandy meander belts in modern sedimentary basins together with their limited recognition in the rock record suggests that their true stratigraphic distribution has yet to be determined. This has important implications for palaeogeographic reconstructions, understanding the impact of plant colonisation on fluvial planform style and predicting sandstone body dimensions and internal heterogeneity distribution within hydrocarbon reservoirs and aquifers

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

One characteristic histopathological event in Alzheimer disease (AD) is cerebral amyloid aggregation, which can be detected by biomarkers in cerebrospinal fluid (CSF) and on positron emission tomography (PET) scans. Prevalence estimates of amyloid pathology are important for health care planning and clinical trial design. To estimate the prevalence of amyloid abnormality in persons with normal cognition, subjective cognitive decline, mild cognitive impairment, or clinical AD dementia and to examine the potential implications of cutoff methods, biomarker modality (CSF or PET), age, sex, APOE genotype, educational level, geographical region, and dementia severity for these estimates. This cross-sectional, individual-participant pooled study included participants from 85 Amyloid Biomarker Study cohorts. Data collection was performed from January 1, 2013, to December 31, 2020. Participants had normal cognition, subjective cognitive decline, mild cognitive impairment, or clinical AD dementia. Normal cognition and subjective cognitive decline were defined by normal scores on cognitive tests, with the presence of cognitive complaints defining subjective cognitive decline. Mild cognitive impairment and clinical AD dementia were diagnosed according to published criteria. Alzheimer disease biomarkers detected on PET or in CSF. Amyloid measurements were dichotomized as normal or abnormal using cohort-provided cutoffs for CSF or PET or by visual reading for PET. Adjusted data-driven cutoffs for abnormal amyloid were calculated using gaussian mixture modeling. Prevalence of amyloid abnormality was estimated according to age, sex, cognitive status, biomarker modality, APOE carrier status, educational level, geographical location, and dementia severity using generalized estimating equations. Among the 19 097 participants (mean [SD] age, 69.1 [9.8] years; 10 148 women [53.1%]) included, 10 139 (53.1%) underwent an amyloid PET scan and 8958 (46.9%) had an amyloid CSF measurement. Using cohort-provided cutoffs, amyloid abnormality prevalences were similar to 2015 estimates for individuals without dementia and were similar across PET- and CSF-based estimates (24%; 95% CI, 21%-28%) in participants with normal cognition, 27% (95% CI, 21%-33%) in participants with subjective cognitive decline, and 51% (95% CI, 46%-56%) in participants with mild cognitive impairment, whereas for clinical AD dementia the estimates were higher for PET than CSF (87% vs 79%; mean difference, 8%; 95% CI, 0%-16%; P = .04). Gaussian mixture modeling-based cutoffs for amyloid measures on PET scans were similar to cohort-provided cutoffs and were not adjusted. Adjusted CSF cutoffs resulted in a 10% higher amyloid abnormality prevalence than PET-based estimates in persons with normal cognition (mean difference, 9%; 95% CI, 3%-15%; P = .004), subjective cognitive decline (9%; 95% CI, 3%-15%; P = .005), and mild cognitive impairment (10%; 95% CI, 3%-17%; P = .004), whereas the estimates were comparable in persons with clinical AD dementia (mean difference, 4%; 95% CI, -2% to 9%; P = .18). This study found that CSF-based estimates using adjusted data-driven cutoffs were up to 10% higher than PET-based estimates in people without dementia, whereas the results were similar among people with dementia. This finding suggests that preclinical and prodromal AD may be more prevalent than previously estimated, which has important implications for clinical trial recruitment strategies and health care planning policies

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

Importance: One characteristic histopathological event in Alzheimer disease (AD) is cerebral amyloid aggregation, which can be detected by biomarkers in cerebrospinal fluid (CSF) and on positron emission tomography (PET) scans. Prevalence estimates of amyloid pathology are important for health care planning and clinical trial design. Objective: To estimate the prevalence of amyloid abnormality in persons with normal cognition, subjective cognitive decline, mild cognitive impairment, or clinical AD dementia and to examine the potential implications of cutoff methods, biomarker modality (CSF or PET), age, sex, APOE genotype, educational level, geographical region, and dementia severity for these estimates. Design, Setting, and Participants: This cross-sectional, individual-participant pooled study included participants from 85 Amyloid Biomarker Study cohorts. Data collection was performed from January 1, 2013, to December 31, 2020. Participants had normal cognition, subjective cognitive decline, mild cognitive impairment, or clinical AD dementia. Normal cognition and subjective cognitive decline were defined by normal scores on cognitive tests, with the presence of cognitive complaints defining subjective cognitive decline. Mild cognitive impairment and clinical AD dementia were diagnosed according to published criteria. Exposures: Alzheimer disease biomarkers detected on PET or in CSF. Main Outcomes and Measures: Amyloid measurements were dichotomized as normal or abnormal using cohort-provided cutoffs for CSF or PET or by visual reading for PET. Adjusted data-driven cutoffs for abnormal amyloid were calculated using gaussian mixture modeling. Prevalence of amyloid abnormality was estimated according to age, sex, cognitive status, biomarker modality, APOE carrier status, educational level, geographical location, and dementia severity using generalized estimating equations. Results: Among the 19097 participants (mean [SD] age, 69.1 [9.8] years; 10148 women [53.1%]) included, 10139 (53.1%) underwent an amyloid PET scan and 8958 (46.9%) had an amyloid CSF measurement. Using cohort-provided cutoffs, amyloid abnormality prevalences were similar to 2015 estimates for individuals without dementia and were similar across PET- and CSF-based estimates (24%; 95% CI, 21%-28%) in participants with normal cognition, 27% (95% CI, 21%-33%) in participants with subjective cognitive decline, and 51% (95% CI, 46%-56%) in participants with mild cognitive impairment, whereas for clinical AD dementia the estimates were higher for PET than CSF (87% vs 79%; mean difference, 8%; 95% CI, 0%-16%; P =.04). Gaussian mixture modeling-based cutoffs for amyloid measures on PET scans were similar to cohort-provided cutoffs and were not adjusted. Adjusted CSF cutoffs resulted in a 10% higher amyloid abnormality prevalence than PET-based estimates in persons with normal cognition (mean difference, 9%; 95% CI, 3%-15%; P =.004), subjective cognitive decline (9%; 95% CI, 3%-15%; P =.005), and mild cognitive impairment (10%; 95% CI, 3%-17%; P =.004), whereas the estimates were comparable in persons with clinical AD dementia (mean difference, 4%; 95% CI, -2% to 9%; P =.18). Conclusions and Relevance: This study found that CSF-based estimates using adjusted data-driven cutoffs were up to 10% higher than PET-based estimates in people without dementia, whereas the results were similar among people with dementia. This finding suggests that preclinical and prodromal AD may be more prevalent than previously estimated, which has important implications for clinical trial recruitment strategies and health care planning policies. © 2022 American Medical Association. All rights reserved